Voluntary evacuations have been approved in 13 countries because of concerns over repercussions from the war in Iraq or terrorism.

Dydrogesterone was first introduced to the market in 1961, and is currently approved in over 100 countries worldwide.

It is approved and marketed in 36 countries outside the United States and had more than $70 million in 1990 sales abroad.

Rebif is already approved in 70 other countries.

The contraceptive has been approved in 16 countries.

It is now approved in more than 50 countries.

But the Apotex drug, deferiprone, has now been approved in more than 30 countries.

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56.

It is now approved in many countries and has been used to treat non-melanoma skin cancer (including basal cell carcinoma).

The patch has been approved in many other countries outside the US under different brand names.